Literature DB >> 7933069

Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis.

C Amici1, C Giorgi, A Rossi, M G Santoro.   

Abstract

Cyclopentenone prostaglandins are potent inhibitors of virus replication. The antiviral activity has been associated with the induction of 70-kDa heat shock protein (HSP70) synthesis. In this report, we describe that in African green monkey kidney cells infected with Sendai virus (SV) and treated with prostaglandin A1 (PGA1), SV protein synthesis was selectively blocked as long as HSP70 was being synthesized by the host cell. The block appeared to be at the translational level, as indicated by the following (i) PGA1 had no effect on SV primary transcription, and a dramatic decrease in the abundance of SV mRNA occurred only at later stages of infection; and (ii) treatment with PGA1 started at 6 h postinfection, at which time SV mRNA had already accumulated in infected cells, did not suppress the levels of NP mRNA, but it reduced the amount of ribosome-bound NP mRNA and caused a dramatic decrease in the level of genomic RNA. The PGA1-induced block of SV protein synthesis appeared to be cell mediated, since it was prevented by actinomycin D, while PGA1 had no effect on SV mRNA translation in vitro. The possibility that HSP70 could be a mediator of the antiviral effect is suggested by the fact that treatment with other classical inducers of HSP70, including sodium arsenite, cadmium, and heat shock at 42 degrees C for 5 h, also selectively prevented SV protein synthesis as long as heat shock protein synthesis occurred. Moreover, SV protein synthesis was not inhibited by PGA1 in murine Friend erythroleukemic cells, which lack the ability to induce HSP70 expression in response to PGA1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7933069      PMCID: PMC237124     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Molecular cloning of the 3'-proximal third of Sendai virus genome.

Authors:  P C Dowling; C Giorgi; L Roux; L A Dethlefsen; M E Galantowicz; B M Blumberg; D Kolakofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

2.  Characterization of Op3, a lysis-defective mutant of bacteriophage f2.

Authors:  P Model; R E Webster; N D Zinder
Journal:  Cell       Date:  1979-10       Impact factor: 41.582

3.  Heat shock protein in mammalian brain and other organs after a physiologically relevant increase in body temperature induced by D-lysergic acid diethylamide.

Authors:  J W Cosgrove; I R Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

4.  Differential inhibition of vesicular stomatitis virus polypeptide synthesis by hypertonic initiation block.

Authors:  D L Nuss; G Koch
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

5.  Antiviral effect of short hyperthermic treatment at specific stages of vesicular stomatitis virus replication cycle.

Authors:  A De Marco; M G Santoro
Journal:  J Gen Virol       Date:  1993-08       Impact factor: 3.891

6.  Selective inhibition of viral gene expression as the mechanism of the antiviral action of PGA1 in vaccinia virus-infected cells.

Authors:  J Benavente; M Esteban; B M Jaffe; M G Santoro
Journal:  J Gen Virol       Date:  1984-03       Impact factor: 3.891

7.  Prostaglandin A inhibits the replication of vesicular stomatitis virus: effect on virus glycoprotein.

Authors:  M G Santoro; B M Jaffe; M Esteban
Journal:  J Gen Virol       Date:  1983-12       Impact factor: 3.891

8.  Prostaglandin A compounds as antiviral agents.

Authors:  M G Santoro; A Benedetto; G Carruba; E Garaci; B M Jaffe
Journal:  Science       Date:  1980-08-29       Impact factor: 47.728

9.  Antiviral effect of prostaglandins of the A series: inhibition of vaccinia virus replication in cultured cells.

Authors:  M G Santoro; B M Jaffe; E Garaci; M Esteban
Journal:  J Gen Virol       Date:  1982-12       Impact factor: 3.891

Review 10.  Molecular basis of fever in humans.

Authors:  C A Dinarello; S M Wolff
Journal:  Am J Med       Date:  1982-05       Impact factor: 4.965

View more
  16 in total

1.  Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation.

Authors:  A Rossi; G Elia; M G Santoro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Assessment of antiviral activity, efficacy, and toxicity of prostaglandin A2 in a rabbit model of herpetic keratitis.

Authors:  W J O'Brien; J L Taylor; H Ankel; G Sitenga
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

3.  Antiviral effect of hyperthermic treatment in rhinovirus infection.

Authors:  C Conti; A De Marco; P Mastromarino; P Tomao; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

4.  HSP70 induced by Hantavirus infection interacts with viral nucleocapsid protein and its overexpression suppresses virus infection in Vero E6 cells.

Authors:  Lu Yu; Ling Ye; Rong Zhao; Yan Fang Liu; Shou Jing Yang
Journal:  Am J Transl Res       Date:  2009-07-15       Impact factor: 4.060

5.  Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection.

Authors:  Masako Unoshima; Hideo Iwasaka; Junko Eto; Yoshiko Takita-Sonoda; Takayuki Noguchi; Akira Nishizono
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Proteomic analysis of purified coronavirus infectious bronchitis virus particles.

Authors:  Qingming Kong; Chunyi Xue; Xiangpeng Ren; Chengwen Zhang; Linlin Li; Dingming Shu; Yingzuo Bi; Yongchang Cao
Journal:  Proteome Sci       Date:  2010-06-09       Impact factor: 2.480

Review 7.  Heat shock proteins in diabetes and wound healing.

Authors:  Mustafa Atalay; Niku Oksala; Jani Lappalainen; David E Laaksonen; Chandan K Sen; Sashwati Roy
Journal:  Curr Protein Pept Sci       Date:  2009-02       Impact factor: 3.272

8.  Inhibition of poliovirus replication by prostaglandins A and J in human cells.

Authors:  C Conti; P Mastromarino; P Tomao; A De Marco; F Pica; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.

Authors:  C Rozera; A Carattoli; A De Marco; C Amici; C Giorgi; M G Santoro
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

Review 10.  Heat shock proteins and virus replication: hsp70s as mediators of the antiviral effects of prostaglandins.

Authors:  M G Santoro
Journal:  Experientia       Date:  1994-11-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.